Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach

Oncogenic forms of NRAS are frequently associated with hematologic malignancies and other cancers, making them important therapeutic targets. Inhibition of individual downstream effector molecules (eg, RAF kinase) have been complicated by the rapid development of resistance or activation of bypass p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Nonami, Atsushi, Sattler, Martin, Weisberg, Ellen, Liu, Qingsong, Zhang, Jianming, Patricelli, Matthew P., Christie, Amanda L., Saur, Amy M., Kohl, Nancy E., Kung, Andrew L., Yoon, Hojong, Sim, Taebo, Gray, Nathanael S., Griffin, James D.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2015
Matèries:
Myeloid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4432008/
https://ncbi.nlm.nih.gov/pubmed/25833960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-12-615906
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars